Career / Job Opportunities
- Quality Control
- Clinical (Operations & Research in support of Clinical trials)
- Medical Affairs
- Regulatory Affairs
- Research & Development
Emergent BioSolutions develops and manufactures vaccines and therapeutics that protect against biological threats such as anthrax, botulism, and smallpox as well as devices that address exposure to chemical threats. The company has products in development for emerging infectious diseases such as Zika, Ebola, and influenza. Emergent has approximately 1,300 employees across 13 locations who are committed to the company mission - to protect and enhance life.
Emergent seeks to provide a stimulating and rewarding work environment where its core values of respect, communication, empowerment, commitment, and innovation are exhibited on a daily basis. Emergent has a deep sense of corporate responsibility and invests in the communities where its employees live and work.
The company offers a wide variety of scientific, technical, and professional career opportunities in many areas, including Manufacturing, Quality, Regulatory Affairs, Medical Affairs, Research & Development, Engineering, Sales, Accounting, HR, IT, Legal Affairs, Public Affairs & Communications, Supply Chain, EHS, and more.
Current opportunities include support for clinical trials in the areas of Quality Control, Manufacturing and Clinical. Professional areas seeing growth also include Sales, Medical Affairs, Regulatory Affairs and Research & Development roles.
For most opportunities at Emergent, potential employees should seek to have education in Science or Engineering, as well as experience in Pharmaceuticals.
"It's great to come to work and be surrounded by such a diverse group of committed, intelligent, and innovative people working together to achieve a common goal,” says Kara Macdonald, Director, Human Resources. “Those who join Emergent will find opportunities for growth on both a personal and professional level as well as opportunities to make meaningful contributions to positively impact public health."